Archived Medical News Stories

RSSArchived Pharmaceutical News Stories - October 2008

Date Title Comments Rating
2008-10-31 GlaxoSmithKline believes there is no liver safety issue with Avandia (rosiglitazone maleate) 0 None
2008-10-29 GSK to acquire Genelabs Technologies 0 None
2008-10-29 FDA grants tentative approval for 75th generic anti-retroviral drug 0 None
2008-10-28 FDA warns Bayer HealthCare on over-the-counter aspirin product 0 None
2008-10-28 New tuberculosis vaccine safer, more effective than BCG vaccine for HIV-positive people 0 None
2008-10-28 How drug companies covertly promote off-label drug use 0 None
2008-10-28 Expensive new diabetes drugs don't necessarily produce better outcomes 0 None
2008-10-28 Sedative propofol could be fatal 0 None
2008-10-27 Improved communication about medications reduces complications among patients using common blood thinner 0 None
2008-10-27 New gout drug offers hope for those who have exhausted treatment options 0 1
2008-10-27 New drugs the next casualty of the credit crunch 0 None
2008-10-26 Gardasil safety questioned, CDC urged to back up statement with data 0 None
2008-10-22 Mylan receives tentative FDA approval for generic versions of Benicar and Uroxatral 0 None
2008-10-22 CytoDyn files new IND for Cytolin 0 None
2008-10-22 Aires Pharmaceuticals signs license agreement with NIH 0 None
2008-10-22 Trius Therapeutics awarded $28 million to develop novel drugs targeting bacterial DNA Gyrase and Topoisomerase IV 0 None
2008-10-20 FDA grants orphan drug status to new 'Trojan Horse' like Ewing's Sarcoma drug 0 None
2008-10-20 Teva granted FDA approval for Fentanyl transdermal system 0 None
2008-10-20 Better TB vaccine in the pipeline 0 None
2008-10-19 FDA approves Astepro, new formulation of Astelin 3 4
2008-10-19 FDA approves new labeling for psoriasis drug Raptiva 0 None
2008-10-16 FDA grants orphan drug status to Reata's pancreatic cancer drug 0 None
2008-10-14 Vioxx heart risks confirmed in long-term study 0 None
2008-10-14 TB Alliance enters into collaboration with sanofi-aventis to fight tuberculosis 0 None
2008-10-13 OncoGenex achieves key regulatory milestone for lead product candidate 0 None
2008-10-13 New maturation inhibitor drugs may help solve HIV treatment conundrum 0 None
2008-10-13 Drug companies plan to invest in HIV/AIDS drug development, improve access, U.N. Secretary-General says 0 None
2008-10-13 Kinaxo partners with Boehringer Ingelheim 0 None
2008-10-12 FDA continues review of Takeda's NDA for Alogliptin 0 None
2008-10-12 FDA licenses Kogenate FS to prevent joint damage in children with hemophilia A 0 None
2008-10-12 FDA approves Rapaflo for treatment of symptoms due to benign prostatic hyperplasia 0 None
2008-10-12 FDA licenses for marketing Cinryze for hereditary angioedema 0 None
2008-10-07 Cheap 'Polypill' deals with heart disease and stroke 0 None
2008-10-06 Lilly to acquire ImClone Systems for $6.5 billion 0 None
2008-10-06 FDA accepts ATryn biologics license application 0 None
2008-10-05 University of Minnesota task force seeks greater transparency in faculty conflicts of interest with pharmaceutical companies 0 None
2008-10-02 Advanced Life Sciences submits NDA for cethromycin in mild-to-moderate community acquired pneumonia 0 None
2008-10-02 Bayer's new oral anticoagulant Xarelto (Rivaroxaban) gets European licence 0 None
2008-10-02 Merck ditches taranabant for obesity 0 None
2008-10-02 Exelixis files investigational new drug application for anticancer compound 1 None


40 posts
4 raters